Altimmune
Altimmune Logo
About Altimmune
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for the treatment of obesity, nonalcoholic steatohepatitis (NASH), chronic hepatitis B, and other liver diseases. Its lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist in Phase 2 trials for obesity and metabolic dysfunction-associated steatohepatitis. The company is also developing HepTcell, an immunotherapeutic product candidate in Phase 2 clinical trials for chronic hepatitis B infection. Altimmune serves patients and healthcare professionals worldwide.
Address
910 Clopper Road, Suite 201S
Gaithersburg, 20878
United States
Year founded
2005
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
